ArticleAmerican journal of hematology2026

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Kenneth J C Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.